Challenge. but none of that. and that is the challenge- but none of that. and that is the challenue. ~ ., ., ~ challenge. when i have worked with some companies challenge. when i have worked with some companies in challenge. when i have worked with some companies in the challenge. when i have worked with some companies in the past - challenge. when i have worked with some companies in the past and i i challenge. when i have worked with l some companies in the past and i am now and invest in some of those companies, the issue has always been how to mitigate risk. china right now present a lot of different types of risks for companies. number one is operating in china with the anti espionage laws making it pretty scary for individual employees of multi nationals to be in china. that is a concern. also the supply chain risk that we became aware of during covid is something that companies are responding to. you have a very high degree of youth unemployment in china that means that t
Over trim. 50 now. it is not a big improvement over trim- now. it is not a big improvement over trim. , ., , over trim. so let s get the thoughts now from joanne over trim. so let s get the thoughts now from joanne mcfeely over trim. so let s get the thoughts now from joanne mcfeely who - over trim. so let s get the thoughts now from joanne mcfeely who is i over trim. so let s get the thoughts now from joanne mcfeely who is a l now from joanne mcfeely who is a partner and portfolio manager at the advisers capital management. let s talk about what these talks aim to achieve. they are far apart on many things but i highlighted some of those areas of common ground and there are a few important areas, but nonetheless, there is still a big challenge ahead, isn t there? yes. i think the end challenge ahead, isn t there? yes. i think the end goal challenge ahead, isn t there? yes. i think the end goal of challenge ahead, isn t there? yes. i think the end goal of normalising i thi